Joseph M. Ortiz MD
Consultant in Ophthalmology, Abington Memorial Hospital, Abington, PennsylvaniaDr. Joseph Ortiz is a consultant in ophthalmology at Abington Memorial Hospital in Pennsylvania. He was formerly Associate Professor of Ophthalmology and Head of the Glaucoma Division and Associate Resident Program Director at Drexel University in Philadelphia. Previously, he held a similar position at Cooper Hospital – UMDNJ in Camden, New Jersey.
He is a diplomate of the American Board of Ophthalmology and a fellow of the American Board of Ophthalmology, the Royal College of Ophthalmologists (UK), and the College of Physicians of Philadelphia. He is a member of the American Glaucoma Society, the Association for Research in Vision and Ophthalmology, the American Association of Ophthalmic Oncologists and Pathologists, and the American Medical Association.
Dr. Joseph M. Ortiz earned his medical degree from New York Medical College, following which he did 1 year of anatomical pathology at Yale – New Haven Hospital, which was then followed by an NIH fellowship in ocular pathology at the Scheie Eye Institute – University of Pennsylvania, where he completed his residency in ophthalmology. This was followed by a glaucoma fellowship at Addenbrooke's Hospital in Cambridge, England. He completed a concurrent fellowship in ocular immune disease at Moorfields Eye Hospital in London.
Recent Contributions to PracticeUpdate:
- Patterns of Glaucoma Medication Adherence Over 4 Years of Follow-Up
- Selective Laser Trabeculoplasty vs Topical Medication for Open-Angle Glaucoma
- Quality of Life After Cataract Surgery for Advanced Glaucoma
- Addition of Bevacizumab Does Not Affect Success Rates for Needle Bleb Revision
- Latanoprost for Open-Angle Glaucoma
- Improved Accuracy of Glaucoma Diagnosis Using Combined Anatomical Measurements
- Steroid-Induced Ocular Hypertension in Children
- 2014 Top Stories in Eye Care: Glaucoma
- Indications for a Systemic Work-Up in Glaucoma
- Confocal Laser Scanning Tomography Predicts Visual Field Conversion in Patients With Ocular Hypertension and Early Glaucoma